Key facts
- This page summarizes SoYoung Kwon's Form 4 filing for Aptevo Therapeutics Inc. (APVO).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 08 Aug 2025, 16:29.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
Footnote F2
The RSUs vest in full on the first anniversary of the date of grant.